Ji-Won Kim
Vermogen: 38 627 $ op 30-06-2026
Vermogen: 38 627 $ op 30-06-2026
Ji-Won Kim currently works at Aju IB Investment Co., Ltd. (Private Equity), as Chief Executive Officer, AJU IB Investment Co., Ltd., as Chief Executive Officer & Director from 1999, and SL VaxiGen, Inc., as Director.
Mr. Kim received his undergraduate degree from Yonsei University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 10-06-2026 | 12.416 ( 0,01% ) | 38 627 $ | 30-06-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| AJU IB INVESTMENT CO., LTD. | Algemeen Directeur | 01-01-1999 |
Aju IB Investment Co., Ltd. (Private Equity)
Aju IB Investment Co., Ltd. (Private Equity) Investment ManagersFinance Aju IB is a long-term investor focused on high technology Korean companies with significant growth potential. Aju IB's investment criteria include management's capability, ethics and transparency, potential market leadership or ability to control the market, technological barriers to entry, significant market size, profitability and maturity. They also take into consideration portfolio diversification. | Algemeen Directeur | - |
SL VaxiGen, Inc.
SL VaxiGen, Inc. Pharmaceuticals: MajorHealth Technology Researches, develops and manufactures vaccine therapeutics | Directeur/Bestuurslid | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Yonsei University
Yonsei University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aju IB Investment Co., Ltd. (Private Equity)
Aju IB Investment Co., Ltd. (Private Equity) Investment ManagersFinance Aju IB is a long-term investor focused on high technology Korean companies with significant growth potential. Aju IB's investment criteria include management's capability, ethics and transparency, potential market leadership or ability to control the market, technological barriers to entry, significant market size, profitability and maturity. They also take into consideration portfolio diversification. | Finance |
AJU IB Investment Co., Ltd.
AJU IB Investment Co., Ltd. Investment ManagersFinance Invests in venture and new technology businesses | Finance |
SL VaxiGen, Inc.
SL VaxiGen, Inc. Pharmaceuticals: MajorHealth Technology Researches, develops and manufactures vaccine therapeutics | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau